ArticleFrontiers in oncology2023

Case Report: PD-L1-negative advanced bladder cancer effectively treated with anlotinib and tislelizumab: A report of two cases.

Teng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.